生物芯片分析技術(shù)可從同一病人樣本獲得多種不同的檢測(cè)結(jié)果，并可迅速得到準(zhǔn)確的結(jié)果。

生物芯片分析技術(shù)是由英國(guó)Randox實(shí)驗(yàn)室研發(fā)設(shè)計(jì)的，這種技術(shù)以酶聯(lián)免疫吸附試驗(yàn)的原理為基礎(chǔ)，尤其是其競(jìng)爭(zhēng)、“三明治”、以及抗體捕獲分析的原理。生物芯片分析技術(shù)利用9mm2的生物芯片作為反應(yīng)平臺(tái)，將多種配體（抗體或抗原）吸附在芯片表面的特定部位。生物芯片可在不同的區(qū)域同時(shí)檢測(cè)23個(gè)不同的項(xiàng)目，僅需7 ml的病人樣本就可獲得23個(gè)不同的結(jié)果。 

生物芯片檢測(cè)經(jīng)過歸類可列成序列，并可同時(shí)對(duì)細(xì)胞因子和生長(zhǎng)因子、孕激素和甲狀腺激素、細(xì)胞黏附分子以及濫用藥物進(jìn)行檢測(cè)。此分析可同時(shí)檢測(cè)與心血管疾病和癌癥相關(guān)的生物標(biāo)記物。生物芯片平臺(tái)適用于蛋白質(zhì)組合基因組的分析，提供更加出色和準(zhǔn)確的檢測(cè)標(biāo)準(zhǔn)。 

Randox公司是一家國(guó)際性診斷公司，在英國(guó)占有主導(dǎo)地位。該公司研發(fā)、制造并且將臨床診斷產(chǎn)品推廣到世界各地。公司的主要產(chǎn)品有：生物芯片分析技術(shù)、臨床化學(xué)分析儀和相應(yīng)的試劑；質(zhì)控品和室間質(zhì)量評(píng)價(jià)（EQA）；環(huán)境診斷產(chǎn)品；重組蛋白和抗體。

Biochip Array Technology Provides Simultaneous Multianalyte Testing 

Biochip array technology allows multiple results from a single patient sample, minimizing biologic variation and resulting in a more rapid and accurate diagnosis.
 
The Biochip array technology was designed by Randox Laboratories (Crumlin, UK) and is based on enzyme-linked immunosorbant assay (ELISA) principles of competitive, sandwich, and antibody capture assays. Biochip array technology utilizes a 9-mm2 biochip as a reaction platform, with multiple specific ligands (antibodies or antigens) attached at pre-defined sites on the surface. Up to 23 separate tests can be spotted as discrete test regions on the surface of the biochip, allowing 23 different results from as little as 7 ml of patient sample. 

Biochip tests are grouped together as arrays and allow the detection of cytokines and growth factors, fertility and thyroid hormones, cell adhesion molecules, and drugs of abuse. Arrays are also available for the detection of biomarkers associated with cardiovascular disease and cancer. The Biochip platform is suitable for both proteomic and genomic analysis, providing test standardization for better performance and accuracy. 

Randox is an international diagnostics company, headquartered in the United Kingdom. The company develops, manufactures, and markets clinical diagnostic products worldwide. The company core products are: Biochip array technology; clinical chemistry analyzers and reagents; quality controls and external quality assessment (EQA); environmental diagnostics; recombinant proteins, and antibodies.